![]() ![]() ![]() If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date. ![]() The use of the eHealthMe site and its content is at your own risk. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. ![]() Different individuals may respond to medication in different ways. Our phase IV clinical studies alone cannot establish cause-effect relationship. WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.ĭISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API). Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Since glucocorticoids are widely used for a variety of diseases, the prevalence of SAI is by far exceeding that of primary adrenal insufficiency. We study millions of patients and 5,000 more each day. Secondary adrenal insufficiency (SAI) is a clinical disorder that results from hypothalamic or hypophyseal damage or from prolonged administration of supraphysiological doses of glucocorticoids. With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |